Savara (SVRA) Other Accumulated Expenses (2012 - 2019)

Savara (SVRA) reported Other Accumulated Expenses of $5000.0 for Q2 2019, down 87.8% quarter-over-quarter from $41000.0 in Q1 2019.

Savara (SVRA) Other Accumulated Expenses (2012 - 2019) Analysis & Trends

Savara (SVRA) has 8 years of Other Accumulated Expenses data on file, last reported at $5000.0 in Q2 2019.

  • Other Accumulated Expenses for Q2 2019 came in at $5000.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2019 was $5000.0 (changed N/A YoY), and the FY2018 annual result was $41000.0, up 485.71% from the prior year.
  • Other Accumulated Expenses fell to $5000.0 in Q2 2019 per SVRA's latest filing, from $41000.0 in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $438000.0 in Q1 2016 and troughed at $5000.0 in Q2 2019.
  • A 5-year average of $204928.6 and a median of $253500.0 in 2015 frame the typical range for Other Accumulated Expenses.
  • The sharpest annual moves came in 2017 and 2018: Other Accumulated Expenses tumbled 96.74% in 2017, then soared 485.71% in 2018.
  • A 5-year view of Other Accumulated Expenses shows it stood at $254000.0 in 2015, then sank by 81.5% to $47000.0 in 2016, then sank by 85.11% to $7000.0 in 2017, then soared by 485.71% to $41000.0 in 2018, then slumped by 87.8% to $5000.0 in 2019.
  • Business Quant data shows SVRA's Other Accumulated Expenses at $5000.0 in Q2 2019, $41000.0 in Q1 2019, and $41000.0 in Q4 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn -
7 Psyence Biomedical 251.43 Bn 251.42 Bn -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn
9 Abivax 94.37 Bn 94.37 Bn -
10 Savara 1.28 Bn 1.28 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2019 5,000.00
Mar 31, 2019 41,000.00
Dec 31, 2018 41,000.00
Dec 31, 2017 7,000.00
Jun 30, 2017 11,000.00
Mar 31, 2017 253,000.00
Dec 31, 2016 47,000.00
Sep 30, 2016 302,000.00
Jun 30, 2016 337,000.00
Mar 31, 2016 438,000.00
Dec 31, 2015 254,000.00
Sep 30, 2015 350,000.00
Jun 30, 2015 436,000.00
Mar 31, 2015 347,000.00
Dec 31, 2014 242,000.00
Sep 30, 2014 257,213.00
Jun 30, 2014 215,582.00
Mar 31, 2014 95,544.00
Dec 31, 2013 221,000.00
Sep 30, 2013 325,944.00